Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible

Pallavi Madhiraju- March 13, 2024 0

In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to ... Read More

Torrent Pharmaceuticals to co-market Saroglitazar Mg with Zydus for liver health

Pallavi Madhiraju- November 10, 2023 0

Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg, a drug for treating Non-Alcoholic Steato Hepatitis ... Read More

FDA approves ZITUVIMET by Zydus Lifesciences for Type 2 diabetes treatment

Pallavi Madhiraju- November 6, 2023 0

Zydus Lifesciences Limited has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for ZITUVIMET, a combination of Sitagliptin and ... Read More

Zydus and Lupin forge alliance for NAFLD and NASH treatment in India

Pallavi Madhiraju- November 6, 2023 0

In a significant move within the pharmaceutical industry, Zydus Lifesciences Limited, renowned for its global lifesciences innovations, and Lupin Limited, a leading global pharma entity, ... Read More

FDA approves Zydus Lifesciences’ ZITUVIO tablets for Type 2 diabetes

Pallavi Madhiraju- October 22, 2023 0

Zydus Lifesciences Limited announced today that the U.S. Food and Drug Administration (FDA) has granted approval for its New Drug Application (NDA) for ZITUVIO (Sitagliptin) ... Read More

Zydus Lifesciences announces Punit Patel as new CEO for Americas operations

Pallavi Madhiraju- October 22, 2023 0

Global lifesciences firm, Zydus Lifesciences Limited, recently declared the appointment of Punit Patel as the President and Chief Executive Officer for its Americas wing. He's ... Read More

Zydus Lifesciences gets FDA final approval for Varenicline Tablets

Pallavi Madhiraju- June 18, 2023 0

Zydus Lifesciences has been granted final approval from the US Food and Drug Administration (FDA) to manufacture and market Varenicline Tablets, 0.5 mg and 1 ... Read More

Zydus Lifesciences to commercialize OncoStem’s CanAssist Breast test

Pallavi Madhiraju- November 16, 2022 0

Zydus Lifesciences has secured exclusive marketing rights to CanAssist Breast, a prognostic test for breast cancer patients in the early stages, from Bengaluru-based OncoStem. According ... Read More

Zydus Lifesciences launches diabetes drugs Sitaglyn and Siglyn in India

pallavi123- July 10, 2022 0

Zydus Lifesciences (Cadila Healthcare) has rolled out the molecule Sitagliptin in India under the Sitaglyn and Siglyn brand names for the treatment of Type 2 ... Read More

Cadila Healthcare bags order for 1cr ZyCoV-D vaccines from Indian govt

pallavi123- November 8, 2021 0

Cadila Healthcare (Zydus Cadila) has bagged an order from the Indian government to deliver one crore doses of its ZyCoV-D Plasmid DNA Covid-19 vaccine. According ... Read More